Treatment of Graf Type IIa Hip Dysplasia: A Cut-off Value for Decision Making.
MATERIALS AND METHODS
This was an Institutional Review Board-approved retrospective review of all patients diagnosed with type IIa hip dysplasia at a single institution from 2012 to 2014. The Graf technique was used at all ultrasound evaluations (5). Patients with a diagnosis of congenital coxa vara, congenital short femur, skeletal dysplasia, or metabolic bone disease were excluded. Patients able to return to the 3 month ultrasound follow-up were included. Hips that progressed to Graf type IIb at the 3 month ultrasound evaluation were treated with a hip abduction orthosis. Informed consent was obtained from all parents of children included in the study.
Radiographic measurements and intra- and inter-observer reliability
All patients had hip ultrasound at about 6 weeks and 3 months of age. The ultrasound parameters were measured by three independent observers (Y.S., O.M.H., and F.B.). Inter- and intra-observer reliability for each measurement was assessed using intra-class correlation coefficients (ICC) calculated from two sets of repeat measurements on a subset of 30 sonograms at least 1 week apart for each observer. Agreement was considered excellent for ICC >0.80, very good for 0.70-0.80, good for 0.60-0.70, fair for 0.40-0.60, and poor for <0.40. Intra- and inter-observer reliability of the [alpha] angle measurements were very good (0.791 and 0.722, respectively). However, the [beta] angle measurements showed good intra- and fair inter-observer reliability (0.661 and 0.537, respectively). The [alpha] and [beta] angles were used as the main outcome measurements to evaluate hip maturation at the last follow-up.
The statistical analysis was performed using SPSS software (SPSS Inc., Chicago, IL, USA). A receiver operating characteristics (ROC) curve was drawn at the 3 month USG to evaluate the cutoff values of the [alpha] and [beta] angles.
Sixty-four patients (46 females an 18 males) with 88 affected hips (63% unilateral and 37% bilateral) were included in this study. Mean age at diagnosis was 6.4[+ or -]2.7 weeks. Fifty-four hips were classified as type IIa(+), and 34 hips were classified as type IIa(-) at the initial ultrasound evaluation. After an observation period of 6 weeks, improvement to type I was seen in 52 type IIa(+) and 17 type IIa(-) hips. According to the 3 month ultrasound measurements, a type IIb transition was seen in only two hips in the type IIa(+) group and in 15 hips in the type IIa(-) group (Figure 2).
ROC analyses showed that patients did well if the [alpha] angle was >55[degrees] on their first ultrasound evaluation (Table 1, Figure 3-5). Patients who had an [alpha] angle <55[degrees] were more likely to develop an immature hip joint at 3 months of age, regardless of the age of the infant at the initial USG [area under the curve (AUC): 0.86; p<0.001 for the left hip and AUC: 0.72; p=0.008 for the right hip]. According to the ROC analyses, there was no cut-off value for the [beta] angle between the treated and untreated groups (Figure 5). No femoral palsies or dislocations were observed related to the use of a harness. All hips improved to type I, and none of the patients needed casting or surgical intervention at the 1-year follow-up.
The high rate of spontaneous improvement reported for DDH (>80%) has led to a considerable dilemma regarding the approach to be used for screening positive infants (6). It has been argued that ultrasound screening techniques lead to the diagnosis of a higher number of DDH cases compared with a physical examination (Ortolani and Barlow clinical tests) and that this can increase the risk of treatment being prescribed unnecessarily (6). However, an early diagnosis and treatment of DDH, made possible by ultrasound screening, can lead complete recovery. Therefore, we evaluated the natural course of type IIa hips using Graf's own perspective of physiological immaturity and maturational deficit.
In Graf's original study, type IIa is divided into two subtypes of type IIa(+) (physiologically immature) and type IIa(-) (maturational deficit), which does not reach the minimum linear maturation rate by age in weeks (5,12,13).
The rate of spontaneous resolution has been reported to be about 95% in type IIa hips (1,11,14-16). Kosar et al. (16) reported that 5.6% of type IIa hips worsen sonographically at follow-up. Central nervous system anomalies, instability, and unilateral type IIa hips were predictors of worsening in their series (16). In our study, a type IIb transition was seen in 19.3% (17 of 88 hips) of type IIa hips at the 3 month ultrasound examination. This transition was more likely to occur in type IIa(-) patients according to the initial [alpha] angle measurements. Omeroglu et al. (7) recommend paying more attention to type IIa hips in newborn girls, as they found a lower rate of spontaneous normalization in newborn girls than in boys. Those authors did not provide the overall rate of spontaneous normalization in type IIa hips at the end of the third month, as they preferred to treat rather than to follow the type IIa(-) hips (7). Graf also recommends treating type IIa(-) hips with an orthosis (8,12). In contrast to the literature, we report a cutoff [alpha] angle value that can be used as a guide for pediatric orthopedic surgeons to predict which hips may worsen. Our study showed that an [alpha] angle <55[degrees] at week 6 of life needs treatment and confirms the value of subtyping type IIa hips as described by Graf (8,12). The skill of physicians in identifying this disorder is controversial in ultrasound-based studies. In our study, there may have been some type IIa cases that were sonographically under-diagnosed or over-diagnosed on the initial ultrasound. All measurements were done by three independent observers to avoid under- or over-diagnosis, eliminate the bias of the physician, and to assess intra- and inter-observer reliability of the [alpha] and [beta] angles. The limitations of this study were mostly caused by its retrospective design. The number of patients was comparatively small, and the duration and modality of treatment were not compared. Prospective controlled studies comparing the effects of observation and orthotic treatment on long-term outcomes of the type IIa hips may be beneficial.
In conclusion, ultrasound follow-up is necessary for all Graf type IIa hips; however, treatment is not necessary for all Graf type IIa hips. An [alpha] angle <55[degrees] on the initial ultrasound was an independent predictor for worsening, and this cutoff value should be considered to prevent future dysplasia. These patients usually require treatment with an orthosis, along with a more careful follow-up.
Conflict of Interest: No conflict of interest was declared by the authors.
Financial Disclosure: No financial disclosure was declared by the authors.
(1.) Tschauner C, Furntrath F, Saba Y, Berghold A, Radl R. Developmental dysplasia of the hip: impact of sonographic newborn hip screening on the outcome of early treated decentered hip joints-a single center retrospective comparative cohort study based on Grafs method of hip ultrasonography. J Child Orthop 2011;5:415-24.
(2.) Puhan MA, Woolacott N, Kleijnen J, Steurer J. Observational studies on ultrasound screening for developmental dysplasia of the hip in newborns - a systematic review. Ultraschall Med 2003;24:377-82.
(3.) Copuroglu C, Ozcan M, Aykac B, Tuncer B, Saridogan K. Reliability of ultrasonographic measurements in suspected patients of developmental dysplasia of the hip and correlation with the acetabular index. Indian J Orthop 2011;45:553-7.
(4.) Omeroglu H. Use of ultrasonography in developmental dysplasia of the hip. J Child Orthop 2014;8:105-13.
(5.) Graf R. New possibilities for the diagnosis of congenital hip joint dislocation by ultrasonography. J Pediatr Orthop 1983;3:354-9.
(6.) Dessi A, Crisafulli M, Vannelli E, Fanos V. Ultrasound in developmental dysplasia of the hip: A screening study in Sardinian newborns. J Ultrasound 2009;12:80-4.
(7.) Omeroglu H, Caylak R, Inan U, Kose N. Ultrasonographic Graf type IIa hip needs more consideration in newborn girls. J Child Orthop 2013;7:95-8.
(8.) Graf R. Hip sonography. Diagnosis and management of infant hip dysplasia. Springer, Berlin: 2006.
(9.) Baronciani D, Atti G, Andiloro F, Bartesaghi A, Gagliardi L, Passamonti C, et al. Screening for developmental dysplasia of the hip: from theory to practice. Collaborative Group DDH Project. Pediatrics 1997;99:E5.
(10.) Rosendahl K, Toma P. Ultrasound in the diagnosis of developmental dysplasia of the hip in newborns. The European approach. A review of methods, accuracy and clinical validity. Eur Radiol 2007;17:1960-7.
(11.) Roovers EA, Boere-Boonekamp MM, Mostert AK, Castelein RM, Zielhuis GA, Kerkhoff TH. The natural history of developmental dysplasia of the hip: sonographic findings in infants of 1-3 months of age. J Pediatr Orthop B 2005;14:325-30.
(12.) Graf R. The diagnosis of congenital hip-joint dislocation by the ultrasonic Combound treatment. Arch Orthop Trauma Surg 1980;97:117-33.
(13.) Graf R. The ultrasonic image of the acetabular rim in infants. An experimental and clinical investigation. Arch Orthop Trauma Surg 1981;99:35-41.
(14.) Chan A, McCaul KA, Cundy PJ, Haan EA, Byron-Scott R. Perinatal risk factors for developmental dysplasia of the hip. Arch Dis Child Fetal Neonatal Ed 1997;76:F94-100.
(15.) Kutlu A, Memik R, Mutlu M, Kutlu R, Arslan A. Congenital dislocation of the hip and its relation to swaddling used in Turkey. J Pediatr Orthop 1992;12:598-602.
(16.) Kosar P, Ergun E, Gokharman FD, Turgut AT, Kosar U. Follow-up sonographic results for Graf type 2A hips: association with risk factors for developmental dysplasia of the hip and instability. J Ultrasound Med 2011;30:677-83.
Fuat Bilgili (1), Yavuz Saglam (2), Suleyman Bora Goksan (1), Onder Murat Hurmeydan (1), Fevzi Birisik (1), Mehmet Demirel (1)
(1) Department of Orthopedics and Traumatology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey
(2) Department of Orthopedics and Traumatology, Biruni University School of Medicine, Istanbul, Turkey
Address for Correspondence: Dr. Mehmet Demirel, Department of Orthopedics and Traumatology, Istanbul University Istanbul School of Medicine, Istanbul, Turkey
e-mail: email@example.com ORCID ID: orcid.org/0000-0003-1131-7719
Received: 25 August 2017 Accepted: 29 June 2018 * DOI: 10.4274/balkanmedj.2017.1150
Cite this article as:
Bilgili F, Saglam Y, Goksan SB, Hurmeydan OM, Birisik F, Demirel M. Treatment of Graf Type IIa Hip Dysplasia: A Cut-off Value for Decision Making. Balkan Med J 2018;35:427-30
TABLE 1. Sensitivity and specificity of the initially measured [alpha] values to predict maturation of both hips at month 3 (The smallest cutoff value is the minimum observed test value minus one, and the largest cutoff value is the maximum observed test value plus one. All other cutoff values are the averages of two consecutive ordered observed test values) L hip Sensitivity 1 Specificity R hip Sensitivity [alpha] [alpha] ([degrees]) ([degrees]) 44.00 1.000 1.000 50.00 1.000 46.50 1.000 0.923 51.50 0.950 48.50 1.000 0.846 52.50 0.950 49.50 1.000 0.769 53.50 0.950 50.50 0.970 0.769 54.50 0.900 51.50 0.939 0.769 55.00 0.650 52.50 0.939 0.615 56.50 0.475 53.50 0.939 0.462 57.50 0.350 54.50 0.939 0.385 58.50 0.125 55.00 0.727 0.154 60.00 0.000 56.50 0.606 0.077 57.50 0.485 0.077 58.50 0.152 0.000 60.00 0.000 0.000 L hip 1 Specificity [alpha] ([degrees]) 44.00 1.000 46.50 0.875 48.50 0.688 49.50 0.562 50.50 0.500 51.50 0.250 52.50 0.188 53.50 0.188 54.50 0.125 55.00 0.000 56.50 57.50 58.50 60.00 PPV and NPV for L hip measurements: 0.44 and 0.96 (respectively) PPV and NPV for R hip measurements: 0.42 and 0.94 NPV: negative predictive values; PPV: posvitive predictive values
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Original Article|
|Author:||Bilgili, Fuat; Saglam, Yavuz; Goksan, Suleyman Bora; Hurmeydan, Onder Murat; Birisik, Fevzi; Demirel|
|Publication:||Balkan Medical Journal|
|Date:||Nov 1, 2018|
|Previous Article:||Can NT-pro BNP Levels Predict Prognosis of Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the Intensive Care Unit?|
|Next Article:||Association Between Superoxide Dismutase Isoenzyme Gene Expression and Total Antioxidant Status in Patients with an End-Stage Renal Disease.|